eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » GlaxoSmithKline - Comment

GlaxoSmithKline - Comment

Document ID: FDA-2011-D-0429-0021
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: September 19 2011, at 12:00 AM Eastern Daylight Time
Date Posted: November 10 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: June 21 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: 
Tracking Number: 80f23d68
View Document:  View as format xml

View Comment

N/A

Attachments:

GlaxoSmithKline Comment

Title:
GlaxoSmithKline Comment

View Attachment: View as format pdf

Related Comments

   
Total: 3
American Institute for Medical and Biological Engineering (AIMBE) - Comment
Public Submission    Posted: 10/18/2011     ID: FDA-2011-D-0429-0019

GlaxoSmithKline - Comment
Public Submission    Posted: 11/10/2011     ID: FDA-2011-D-0429-0021

University of Minnesota Law School - Comment
Public Submission    Posted: 11/10/2011     ID: FDA-2011-D-0429-0022